ArticleCureus2025
Progressive Purpura in Microscopic Polyangiitis: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpura is one of the most common cutaneous manifestations of microscopic polyangiitis (MPA), typically presenting as palpable lesions on the lower extremities due to leukocytoclastic vasculitis. Although nonspecific, these findings often appear early and may provide important diagnostic clues before life-threatening organ involvement becomes evident. A 72-year-old woman presented with a two-month history of dry cough and a one-month history of bilateral femoral myalgia. Physical examination revealed fine crackles in the bilateral lower dorsal lung fields and localized purpura on her right lower extremity. Grasping of the limbs elicited tenderness in the bilateral quadriceps femoris, tibialis anterior, and extensor hallucis longus. A plain chest computed tomography scan revealed interstitial opacities in the subpleural regions of both lungs. Laboratory tests showed a hemoglobin level of 9.5 g/dL and a C-reactive protein level of 8.81 mg/dL. Urinalysis revealed proteinuria (0.32 g/gCr) without hematuria. Five days after the initial presentation, palpable purpura was noted on both lower extremities, along with tingling pain radiating from the dorsal feet to the toes. Myeloperoxidase-anti-neutrophil cytoplasmic antibody (MPO-ANCA) was elevated at 16.4 IU/mL. Nerve conduction studies revealed an axonal degeneration pattern in the bilateral lower limbs. A skin biopsy demonstrated leukocytoclastic vasculitis within the dermis, indicating vasculitis. Based on these findings, MPA was diagnosed. Treatment with prednisolone and azathioprine resulted in the rapid resolution of the purpura. This case underscores the importance of recognizing unilateral or progressive purpura as an early diagnostic clue of MPA, even before renal or pulmonary involvement becomes evident.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.